EP2790718
ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.12.2012EP published:
7.2.2018EP application number:
12799204.8
EPO information:
European Patent Register
Max expiry date:
11.12.2032
Title:
ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3
Timeline
Today
12.12.2012EP application
7.2.2018EP Publication
Owner
Name:
Institut National de la Santé et de la Recherche Médicale (INSERM)Address:
101, rue de Tolbiac, 75013, Paris, FR
Name:
Université Paris DescartesAddress:
12, rue de l'Ecole de Médecine, 75006, Paris, FR
Name:
Centre National de la Recherche Scientifique (C.N.R.S.)Address:
3, rue Michel-Ange, 75016, Paris, FR
Name:
Assistance Publique Hôpitaux de ParisAddress:
3 Avenue Victoria, 75004, Paris, FR
Name:
Université Paris Diderot - Paris 7Address:
5, rue Thomas Mann, 75013, Paris, FR
Name:
ImagineAddress:
24, Boulevard du Montparnasse, 75015, Paris, FR
Inventor
Name:
LEGEAI-MALLET, LaurenceAddress:
Paris, FR
Name:
MUNNICH, ArnoldAddress:
PARIS, FR
Name:
BUSCA, PatriciaAddress:
PARIS, FR
Name:
BARBAULT, FlorentAddress:
75205 PARIS Cedex 13, FR
Priority
Number:
PCT/IB2011/003253Date:
12.12.2011Country:
WO
Classification
Categories:
A61K 38/17, A61K 31/519, A61P 19/00, A61K 31/506